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Edited by Maurice MontalAbstract Several families of peptide toxins from cone snails
aﬀect voltage-gated sodium (NaV) channels: l-conotoxins block
the pore, d-conotoxins inhibit channel inactivation, and lO-cono-
toxins inhibit NaV channels by an unknown mechanism. The only
currently known lO-conotoxins MrVIA and MrVIB from Conus
marmoreus were applied to cloned rat skeletal muscle (NaV1.4)
and brain (NaV1.2) sodium channels in mammalian cells. A
systematic domain-swapping strategy identiﬁed the C-terminal
pore loop of domain-3 as the major determinant for NaV1.4 being
more potently blocked than NaV1.2 channels. lO-conotoxins
therefore show an interaction pattern with NaV channels that is
clearly diﬀerent from the related l- and d-conotoxins, indicative
of a distinct molecular mechanism of channel inhibition.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Voltage-gated sodium channels (NaV channels) are key ele-
ments for the generation of action potentials of electrically
excitable cells [1]. The fast activation and inactivation of these
channels is crucial for shaping the upstroke depolarization of
an action potential. A variety of neurotoxins from diﬀerent
organisms act on NaV channels and aﬀect the cellular excitabil-
ity (e.g., [2–5]). Several families of peptide toxins from the
venom of cone snails modulate NaV channels: l-conotoxins
and lO-conotoxins block channel conductance, whereas d-
conotoxins increase currents by inhibiting inactivation [6].
The l-conotoxins ‘‘block’’ the channel by interacting with
receptor site-1, which is the binding site of the classical NaV
channel blockers tetrodotoxin (TTX) and saxitoxin (STX) (re-Abbreviations: NaV channels, voltage-gated sodium channels; TTX,
tetrodotoxin; STX, saxitoxin
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doi:10.1016/j.febslet.2006.01.057view: [7]). l-Conotoxins belong to the M-superfamily, d- and
lO-conotoxins to the O-superfamily of conopeptides. The lat-
ter have a cysteine backbone, which is diﬀerent from the one of
l-conotoxins but similar to that of x-conotoxins, which inter-
act with voltage-gated Ca2+ channels. d-Conotoxins interact
with receptor site-6 of NaV channels. Our recent study [8],
however, showed that d-conotoxins, like scorpion a-toxins or
sea anemone toxins, interact with the S3/4 linker of domain-
4. Hence, receptor site-3 and site-6 seem to be overlapping
structural entities.
Despite their structural similarities to d-conotoxins, lO-
conotoxins block sodium current and apparently do not slow
inactivation [9]. In addition, they seem to have blocking po-
tency for calcium channels [10]. Competition studies with la-
beled STX suggest that lO-conotoxins do not block NaV
channels by interacting with receptor site-1 [11]. The site of ac-
tion and the mechanism through which lO-conotoxins aﬀect
NaV channels are still unknown.
There is considerable interest in elucidating such mecha-
nisms because uniquely, lO-conotoxins seem to block TTX-
resistant sodium channels eﬀectively (NaV1.8 [12]). These
channels are expressed in peripheral nerves, and their speciﬁc
suppression may provide an analgesic strategy. Systematic
studies are, however, hampered by the complication of
expressing NaV1.8 channels in mammalian cells. In addition,
thus far no marked subtype speciﬁcity of the toxins that would
allow for a systematic search for binding sites or molecular
mechanisms of channel modulation has been shown.2. Materials and methods
2.1. Construction of channel chimeras
The rat channel isoforms NaV1.2 (X03639 [13]) and NaV1.4
(M26643.1 [14]) were expressed from the vectors pCIneo and pcDNA3,
respectively. Using PCR-based site-directed mutagenesis, three silent
mutations (C3121G, G3123A, and C3868T) were introduced into the
NaV1.4 ORF to generate an NheI restriction site at position 3121 and
a ClaI site at position 3864. These two restriction sites, an endogenous
BsiWI site (position 1329), a BstEII site at the 3 0 end, and an XbaI site
at the 5 0 end of the channel-coding gene were used to extract DNA frag-
ments coding for the four channel domains (domain-1: BstEII/BsiWI,
domain-2: BsiWI/NheI, domain-3: NheI/ClaI, domain-4: ClaI/XbaI).
DNA fragments coding for the homologous parts of NaV1.2 were sub-
cloned into the pGEMT vector (Promega Corp., Madison, USA) with
primers that introduced restriction sites for BsiWI, NheI, ClaI, BstEII,blished by Elsevier B.V. All rights reserved.
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introduced into NaV1.4 resulting in four chimeras in which individual
domains of NaV1.4 are replaced by those of NaV1.2: 2444 (domain-1),
4244 (domain-2), 4424 (domain-3), and 4442 (domain-4). In addition,
we generated mutants in the background of wild-type NaV1.4 (‘‘44p4’’:
E1251N, K1252V, E1254L, H1257K, and V1260D) and NaV1.2
(‘‘22p2’’: N1436E, V1437K, L1439E, K1442H, and D1445V) channels.
2.2. Toxin synthesis
MrVIA/B were synthesized using a modiﬁcation of a method de-
scribed previously [9]. The peptides were assembled on an automatic
peptide synthesizer using 9-ﬂuorenylmethoxycarbonyl (Fmoc) chemis-
try on a preloaded Fmoc-Val-Wang resin. It was removed from the resin
by a 3-h treatment with reagentK and precipitated with coldmethyl-ter-
tbutyl ether (MTBE) chilled to20C. The precipitate was washed four
times with cold MTBE. A reversed-phase HPLC puriﬁcation of a re-
duced peptide was performed using a preparative diphenyl column (Vy-
dac, model 219TP510) with a linear gradient of 90% acetonitrile/0.1%
TFA in water, ranging from 30% to 90%. The ﬁrst oxidation step was
carried out by mixing the following reaction components (ﬁnal concen-
trations in parentheses): isopropanol (30%), water, Tris–HCl buﬀer, pH
8.7 (100 mM), EDTA (1 mM), GSSG (1 mM), GSH (2 mM). The reac-
tion was quenched with formic acid (1%) and then separated on the pre-
parative diphenyl HPLC column. The second folding step includedFig. 1. Block of NaV1.4 channels by MrVIA and MrVIB. (A) Alignment of M
responses to depolarizations to 20 mV for NaV1.4 channels expressed in
indicated concentrations of MrVIA. The panel on the right shows the traces r
in magnitude by the factors 1.135 (100 nM), 2.30 (400 nM), and 4.01 (800 nM
presence of 400 and 800 nMMrVIA resulted in weak current block (scaling fa
every 30 s and the peak current is plotted here as a function of time under the
data assuming that the block obeys an on-rate of 1/(s = 12.800 s/conc[nM]))
blocking NaV1.4 channels by MrVIA (open) and MrVIB (ﬁlled circles). The
NaV1.2 channels.formation of the disulﬁde bond between Cys9 and Cys25 and was car-
ried out in 40% acetonitrile, and 1 mM iodine, 2.5% TFA for 20 min
at room temperature. The oxidation product was puriﬁed on the diphe-
nyl preparative HPLC column, as described for the linear form.
2.3. Electrophysiological measurements
Cultivation and transfection of HEK 293 cells as well as whole-cell
voltage clamp experiments and toxin application were performed as
described previously [15]. The patch pipettes contained (mM): 35
NaCl; 105 CsF; 10 EGTA; and 10 HEPES (pH 7.4 with CsOH). The
bath solution contained (mM): 150 NaCl; 2 KCl, 1.5 CaCl2; 1 MgCl2;
and 10 HEPES (pH 7.4 with NaOH). The toxins were stored frozen in
extracellular bath solution additionally containing 1 mg/ml BSA.
Channel activation was assayed by test depolarizations from 80 to
+60 mV at an interval of 10 s. The peak currents were ﬁt with a Hodg-
kin–Huxley activation formalism involving three activation gates and a
single-channel characteristic according to the Goldman–Hodgkin–
Katz equation:
IpeakðV Þ ¼ Imaxð1þ eðVV mÞ=km Þ3
Imax ¼ CV 1 e
ðVErevÞ=25mV
1 eV =25mV
ð1ÞrVIA and MrVIB indicating the disulﬁde bridge structure. (B) Current
HEK 293 cells under control conditions and after application of the
ecorded in the presence of toxin superimposed to the control and scaled
). (C) A similar experiment as in (B) but with NaV1.2 channels. The
ctors of 1.13 and 1.22, respectively). (D) Pulses to 20 mV were elicited
indicated applications of MrVIA. The superimposed curve is a ﬁt to the
and an oﬀ-rate of 1/(s = 180 s). (E) Concentration–response curves for
continuous curves are Hill ﬁts (Eq. (3)). The squares indicate data for
1362 S. Zorn et al. / FEBS Letters 580 (2006) 1360–1364where Vm is the voltage of half-maximal gate activation and km the
corresponding slope factor. C is the maximal conductance of all chan-
nels and Erev the reversal potential.
Voltage dependence of fast inactivation was evaluated by measuring
current at 20 mV after 500-ms conditioning pulses ranging from
140 to 30 mV (repetition interval of 15 s). The peak current versus
the conditioning voltage was described with a Boltzmann function:
IðV Þ ¼ Iminð1þ eðVV hÞ=kh Þ ð2Þ
with the half-maximal inactivation voltage Vh and the corresponding
slope factor kh.
Toxin dependence of current inhibition was measured under repeti-
tive pulsing to 20 mV at an interval of 15 s. The dose dependence for
toxin-induced current reduction was described with the Hill equation:
I=Ic ¼ 1
1þ conc
IC50
 h ð3Þ
where h is the Hill coeﬃcient and conc the toxin concentration. IC50
provides a measure for the concentration of half-maximal channel
inhibition. Data points were weighted according to the standard error
of the mean; error estimates for IC50 values were obtained from these
ﬁts with the IgorPro program (WaveMetrics, Lake Oswego, OR,
USA). The holding potential was 120 mV for all experiments.
Data acquisition and analysis were performed with PatchMaster and
FitMaster software, respectively (HEKA Elektronik, Lambrecht, Ger-
many). All data were presented as means ± S.E. of the mean (n = num-
ber of independent experiments).Fig. 2. Voltage-dependent parameters. (A) Current–voltage relation-
ship for NaV1.4 channels under control conditions (open circles) and
after application of 400 nM MrVIA (ﬁlled circles). The continuous
curves are data ﬁts according to a Hodgkin and Huxley activation
model (Eq. (1)). The broken continuous curve superimposed to the
control data is the ﬁt resulting from the toxin data, scaled by a factor
of 3.6. (B) Steady-state inactivation curve (Eq. (2)) for the same cell as
in (A) and using the same symbols.3. Results and discussion
3.1. Block of rNaV1.4 and rNaV1.2 channels by lO-conotoxins
RatNaV1.4 channels were expressed inHEK 293 cells and the
eﬀects of the lO-conotoxinsMrVIA andMrVIB (Fig. 1A) were
assayed under whole-cell patch clamp conditions. As shown in
Fig. 1B, application of increasing concentrations of MrVIA re-
duced the current magnitude when channel activity was mea-
sured under repetitive pulses to 20 mV. The time course of
the remaining current did not signiﬁcantly diﬀer from the con-
trol as shown in the scaled-up version in the rightmost panel of
Fig. 1B. Fig. 1C shows similar experiments performed with
NaV1.2 channels. Even 800 nM MrVIA exhibits only a very
small blocking eﬀect on the evoked currents. Furthermore, the
time course of the currents in the presence of the toxin is not al-
tered either. Similar results were obtained with MrVIB. Thus,
MrVIA and MrVIB, unlike the structurally related d-conotox-
ins, do not aﬀect the time course of channel activation or inacti-
vation. In Fig. 1D, the time course of peak currents is shown for
the indicated applications of MrVIA. The current is blocked
rapidly and reversibly. The continuous curve is a data ﬁt assum-
ing a block on-rate of 780/(ms nM) and an oﬀ-rate of 5.5/ms.
Therefore, the on-rate is roughly a linear function of toxin con-
centration and the oﬀ-rate seems to be independent of toxin con-
centration indicating a simple bimolecular reaction. The
potency of the toxins to reduce the NaV1.4-mediated current
amplitude was estimated by compiling concentration–response
curves (Fig. 1E), described by a Hill equation (Eq. (3)), yielding
IC50-values of 265 ± 16 and 222 ± 18 nM, and Hill coeﬃcients
of 1.32 ± 0.10 and 1.31 ± 0.12 for MrVIA and MrVIB, respec-
tively. Thus, the toxins display an indistinguishable potency to
block NaV1.4 channels. A Hill coeﬃcient close to unity suggests
that one toxin molecule might be suﬃcient for channel block.
Thediﬀerence of toxin eﬀect onmuscle andbrain channelswas
not expected because Safo et al. [16] reported that MrVIA didnot discriminate well between rNaV1.4 (IC50 438 nM), rNaV1.2
(532 nM), and rNaV1.7 (345 nM) when the channels were ex-
pressed inXenopus oocytes. Presently we do not know the diﬀer-
ences between those results and ours obtained in HEK 293 cells.
Nevertheless, our experiments clearly demonstrate that MrVIA
has a preference for NaV1.4 over NaV1.2 channels. This prefer-
ence and the absolute potency is the same for MrVIA and
MrVIB, indicating that the minor sequence diﬀerences between
the two toxins (see Fig. 1A) have no eﬀect on the toxin interac-
tion with the mammalian channel types assayed.
The current reduction induced by the MrVI toxins did not
depend on the magnitude of membrane depolarization. As
shown in Fig. 2A, 400 nM MrVIA reduced the peak current
of NaV1.4 channels to the same extent throughout a complete
current–voltage recording. In addition, no strong shift in stea-
dy-state inactivation is observed in the presence of toxins
(Fig. 2B). For wild-type NaV1.4 channels Vh was
75.5 ± 1.8 mV before and 82.2 ± 1.9 mV (n = 6) after appli-
cation of 400 nMMrVIA. Thus, since the holding voltage used
in this study was 120 mV throughout, we can safely exclude a
shift of steady-state inactivation as cause for lO-conotoxin-in-
duced current block. The averaged parameters characterizing
channel activation and inactivation are listed in Table 1.
3.2. Identiﬁcation of domain-3 as a major interaction site
The diﬀerence in the toxin eﬀect on NaV1.4 over NaV1.2
channels provide the opportunity to systematically search for
domains in the channel protein important for toxin action.
This is particularly intriguing, as currently there is no informa-
tion on the channel binding sites occupied by lO-conotoxins.
For an initial screening we generated chimeras between
NaV1.4 and NaV1.2 channels in which the majority of the
Table 1
Steady-state activation and inactivation parameters as well as current block by 400 nM MrVIA characterizing wild-type channels and channel
chimeras
Channel Vm (mV) km (mV) n Vh (mV) kh (mV) n % Block n
rNaV1.4 (4444) 45.6 ± 1.9 10.2 ± 0.7 10 75.1 ± 1.9 5.0 ± 0.2 10 68.4 ± 1.1 22
rNaV1.2 (2222) 39.2 ± 3.3 12.2 ± 0.2 5 72.6 ± 3.0 4.8 ± 0.1 5 13.6 ± 2.8 8
2444 45.7 ± 1.1 10.0 ± 0.3 4 73.9 ± 0.8 5.0 ± 0.2 5 62.8 ± 2.6 9
4244 42.9 ± 2.1 10.4 ± 0.3 7 75.9 ± 1.7 5.2 ± 0.1 7 67.9 ± 4.9 11
4424 41.5 ± 1.8 8.7 ± 0.9 5 71.5 ± 0.7 4.9 ± 0.2 5 16.2 ± 1.5 5
4442 49.3 ± 2.4 10.4 ± 0.6 6 79.7 ± 1.8 5.3 ± 0.1 6 71.0 ± 2.6 9
44p4 46.0 ± 1.0 9.2 ± 0.3 8 73.3 ± 0.9 4.6 ± 0.1 8 19.9 ± 3.0 8
22p2 44.0 ± 1.3 12.4 ± 0.5 4 76.4 ± 1.4 4.9 ± 0.1 4 46.3 ± 3.9 6
Vm and km values determined from current–voltage relationships according to Eq. (1), Vh and kh values from steady-state inactivation protocols
according to Eq. (2), and the percentage of current block upon application of 400 nM MrVIA.
S. Zorn et al. / FEBS Letters 580 (2006) 1360–1364 1363construct was from NaV1.4: Individual domains were ex-
changed between the two channel isoforms yielding the con-
structs 2444, 4244, 4424, and 4442 as depicted in Fig. 3A.
All domain chimeras were assayed for the eﬀect of 400 nM
MrVIA yielding strong current block, i.e. a NaV1.4 phenotype,
in all chimeras but 4424. This result is somewhat surprising as
this is the ﬁrst case in which domain-3 is the major determinant
for the discrimination of channel isoforms by neurotoxins.
All chimeras were also investigated with respect to the volt-
age dependence of activation and fast inactivation. As listed in
Table 1, none of the chimeras dramatically deviated from theFig. 3. Chimeras and assay of toxin eﬀects. (A) Cartoons illustrating the cons
in black, parts from NaV1.2 in grey. In chimeras ‘‘44p4’’ and ‘‘22p2’’ the SS2
(B) Superimposed current traces of the corresponding channel constructs ob
after application of 400 nM MrVIA (grey shading). (C) Average block of pea
constructs. The error bars denote S.E.M. values and the numbers in parenthwild-type NaV1.4 channel indicating that the observed diﬀer-
ences in toxin eﬀect are not due to altered gating characteristics
introduced by formation of the chimeras.
To further narrow down a potential interaction site between
lO-conotoxins and NaV channels, we constructed another chi-
mera in which only the C-terminal part of the pore loop (SS2) of
NaV1.2 was transferred into NaV1.4 (Fig. 3A, bottom). This
part of the pore loop only contains ﬁve diﬀerences between
the channel isoforms. The assay with 400 nM MrVIA also
yielded a strong reduction in the blocking potency (Fig. 3B, bot-
tom) suggesting that SS2 plays a major role in the binding oftruction of channel chimeras. Parts originating from NaV1.4 are shown
pore loops of domain-3, indicated by the arrows, have been exchanged.
tained upon depolarization to 20 mV under control conditions and
k current after application of 400 nM MrVIA for the indicated channel
eses the numbers of experiments.
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eﬀect induced by mutagenesis at ﬁve positions may be rather
accidental, we generated the reverse chimera, i.e. a NaV1.2
channel with the SS2 pore loop of domain-3 from NaV1.4. This
chimera was blocked much more eﬃciently than the corre-
sponding wild-type NaV1.2 (Fig. 3, last row), clearly showing
that the identiﬁed region is a major determinant for the action
of lO-conotoxins. These data therefore add a new molecular
entity to the interaction sites of biologically active neurotoxins
on NaV channels.
lO-conotoxins, although they exhibit structural similarities to
d-conotoxins, do not aﬀect inactivation of NaV channels, but in-
stead block the channel conductance. This eﬀect seems similar to
that of l-conotoxins. However, binding studies with
radiolabeled STX indicated that lO-conotoxin MrVIA is not
interacting with receptor site-1 of the channel [11]. In contrast
tol-conotoxins, whichmakemultiple couplings to the pore loop
of diﬀerent channel domains of the NaV channel a-subunit
[6,17], our data indicate that lO-conotoxins do blockNaV chan-
nels by interacting mainly with the C-terminal part of the pore
loop of domain-3. The pore regions of the domains 1, 2, and 4
seem tobe less important forlO-conotoxin binding, at least they
are not crucial for the diﬀerence between NaV1.2 and NaV1.4
channels. The pore loop of domain-3, however, also seems to
be important for the binding of scorpion b-toxins [18,19].3.3. Potential value of lO-conotoxins
The diﬀerences of MrVIA eﬀects on NaV1.4 and NaV1.2
channels could be used to identify potential interaction sites
at the channel protein. However, higher concentrations of
MrVIA also aﬀect NaV1.2 channels and they even seem to aﬀect
CaV channels [10]. Therefore, the overall speciﬁcity of lO-
conotoxins seems to be rather weak and not comparable to
the speciﬁcity observed for structurally related x-conotoxins
that block CaV channels. Since lO-conotoxins also block
TTX-resistant NaV1.8 channels in dorsal root ganglia neurons
involved in pain sensation [12], these peptides might be impor-
tant tools for studying these channels. Furthermore, the known
structure of lO-conotoxins [12] might serve as a starting point
for developing substances that speciﬁcally block NaV1.8 chan-
nels; this could be a major breakthrough for the development of
new analgetics. The results presented in this study can pave the
way for a deeper understanding of the speciﬁcity of lO-cono-
toxins towards diﬀerent NaV channel subtypes.
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